imiquimod has been researched along with Extra-Mammary Paget Disease in 70 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 19 (27.14) | 29.6817 |
| 2010's | 36 (51.43) | 24.3611 |
| 2020's | 15 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Aasi, SZ; Alam, M; Arai, N; Aung, PP; Barker, CA; Bolotin, D; Bordeaux, JS; Brackett, A; Cartee, TV; Chandra, S; Cho, NL; Choi, JN; Chung, KY; Cliby, WA; Dorigo, O; Downing, MB; Eisen, DB; Fujisawa, Y; Golda, N; Halfdanarson, TR; Harikumar, V; Iavazzo, C; Ibrahim, SA; Jiang, SIB; Kang, BY; Kanitakis, J; Khan, A; Kibbi, N; Kim, JYS; Kuzel, TM; Lawrence, N; Leitao, MM; MacLean, AB; Maher, IA; Mittal, BB; Nehal, KS; Owen, JL; Ozog, DM; Pettaway, CA; Poon, E; Ross, JS; Rossi, AM; Servaes, S; Solomon, MJ; Thomas, VD; Tolia, M; Voelzke, BB; Waldman, A; Wang, JX; Wong, MK; Worley, B; Zhou, Y | 1 |
| Boll, D; Bulten, J; de Hullu, JA; Esajas, MD; Meeuwis, KA; van Beurden, M; van der Linden, M; van Dorst, EB; van Hees, CL; van Poelgeest, MI | 1 |
| Benedetto, C; Bertero, L; Borella, F; Gallio, N; Micheletti, L; Pérez-López, FR; Preti, M; Vieira-Baptista, P | 1 |
| Bevilacqua, F; Bleeker, MCG; Bornstein, J; Carcopino, X; Chargari, C; Cruickshank, ME; Erzeneoglu, BE; Esat Temiz, B; Gallio, N; Gultekin, M; Heller, D; Joura, E; Kesic, V; Planchamp, F; Preti, M; Querleu, D; Reich, O; Stockdale, CK; Van Beurden, M; Vieira-Baptista, P; Woelber, L; Zodzika, J | 1 |
| Bevilacqua, F; Bleeker, MCG; Bornstein, J; Carcopino, X; Chargari, C; Cruickshank, ME; Erzeneoglu, BE; Gallio, N; Gultekin, M; Heller, D; Joura, E; Kesic, V; Planchamp, F; Preti, M; Querleu, D; Reich, O; Stockdale, CK; Temiz, BE; Van Beurden, M; Vieira-Baptista, P; Woelber, L; Zodzika, J | 1 |
| Fotiou, A; Gkegkes, ID; Iavazzo, C | 1 |
| Bargman, H; Sachdeva, M; Tai, F | 1 |
| Chung, PH; D'mello, D; Jones, EK; Leong, JY; Shumaker, A | 1 |
| Cao, X; Xue, R; Yuan, X | 1 |
| Carton, I; Henno, S; Lavoué, V; Lebreton, M; Levêque, J; Nyangoh-Timoh, K; Tesson, C | 1 |
| Benedetto, C; Bertero, L; Bevilacqua, F; Borella, F; Carosso, AR; Cassoni, P; Castellano, I; Collemi, G; Cosma, S; Gallio, N; Micheletti, L; Preti, M | 1 |
| Kim, JK; Thompson, HM | 1 |
| Choi, S; Chung, KY; Oh, BH; Oh, Y; Roh, MR | 1 |
| Buckley, K; Chung, CG; Sheldon, JD; Ulman, C | 1 |
| Chang, CH; Li, MH; Lin, JD; Wu, TH | 1 |
| Hutson, R; Nama, V; Parashurama, R | 1 |
| Hida, T; Horimoto, K; Kato, J; Sato, S; Sawada, M; Uhara, H; Yamashita, T; Yoneta, A | 1 |
| Bauman, TM; Rosman, IS; Sheinbein, DM | 1 |
| Apalla, Z; Ioannides, D; Lallas, A; Nikolaidou, C; Sotiriou, E; Tsorova, A; Vakirlis, E | 1 |
| Eberhardt, J; Gray, A; Gray, J; Mudaliar, K; Swan, J; Tung, R | 1 |
| Bonafé, GA; Dos Santos, JS; Kanno, DT; Martinez, CAR; Ortega, MM; Pereira, JA | 1 |
| Bulten, J; de Hullu, JA; Fons, G; Lok, CAR; Massuger, LFAG; Oonk, MHM; Slangen, BMF; van der Linden, M; van Doorn, HC; van Dorst, EBL; van Poelgeest, MIE | 1 |
| Chen, L; Cornelius, LA; Demehri, S; Faulkner-Jones, BE; Khalifian, S; Molina, GE; Mull, JL; Ngo, KH; Rosman, IS; Wu, PA | 1 |
| Innamaa, A; Lippiatt, J; Melson, L; Mujukian, A | 1 |
| Bouceiro-Mendes, R; Correia-Fonseca, I; Mendonça-Sanches, M; Soares-de-Almeida, L | 1 |
| Allan, E; Bryant, A; Cooper, S; Edey, KA; Murdoch, JB | 1 |
| Innamaa, A; Palmer, J; Sanderson, P; Tidy, J | 1 |
| Buttmann, N; Clad, A; Gieseking, F; Harter, P; Lellé, RJ; Luyten, A; Maass-Poppenhusen, K; Petry, KU; Sörgel, P | 1 |
| Jiayuan, C; Jing, W; Juan, X; Li, X; Qin, H; Qing, L; Shengmei, X | 1 |
| Evangelia Iavazzo, P; Gkegkes, ID; Iavazzo, C; Karachalios, C; Ntziora, F | 1 |
| Berasategui, MT; Gogorza, S; Lopez, DG; Marchitelli, C; Peremateu, MS; Sluga, MC; Velazco, A; Wernicke, A | 1 |
| Machida, H; Matsuo, K; Moeini, A; Roman, LD | 1 |
| Abu-Rustum, NR; Backes, FJ; Black, DR; Chi, DS; Cowan, RA; Eisenhauer, EL; Gardner, GJ; Hoang, LN; Leitao, MM; Park, KJ; Soslow, RA | 1 |
| Aw, CW; Liau, MM; Tan, KB; Yang, SS | 1 |
| Cetin, C; Dogan, A; Grimm, C; Hefler, LA; Hilal, Z; Krentel, H; Tempfer, CB | 1 |
| Geisler, JP; Manahan, KJ | 1 |
| Challenor, R; Fitton, AR; Hughes, G | 1 |
| Festa Neto, C; Niwa, AB; Sanches, JA; Tanaka, VD; Torezan, L | 1 |
| Benito, DM; Casado, M; Feito, M; Feltes, R; Floristán, U; Herranz, P; Ramírez, P; Sendagorta, E | 1 |
| Han, TY; Hong, CK; Li, K; Park, J; Seo, SJ; Song, KY; Yoo, KH | 1 |
| Bartoli, L; Brunetti, L; Cecchi, R; Pavesi, M; Rapicano, V | 1 |
| Bertozzi, S; Fruscalzo, A; Lellé, RJ; Londero, AP; Marchesoni, D | 1 |
| Güngor, T; Ozat, M; Sahin, I; Sirvan, L; Tonguc, E; Var, T | 1 |
| Bhalerao-Gandhi, A; Khan, KJ; Madnani, NA | 1 |
| Gómez-Moyano, E; Hiraldo-Gamero, A; Sánchez-Fajardo, F; Sanz-Trelles, A; Segura-Palacios, JM | 1 |
| Anolik, R; Brightman, L; Geronemus, R; Warycha, M | 1 |
| Gil-Bistes, D; Guillot, B; Kluger, N; Rigau, V | 1 |
| Burkemper, NM; Fosko, SW; Green, JS | 1 |
| Heine, M; Sachse, MM; Wagner, G | 1 |
| Anton, C; Baracat, EC; Carvalho, FM; Carvalho, JP; Luiz, AV | 1 |
| Izumi, AK; Jim On, SC | 1 |
| Cerio, R; Gibbon, K; Harwood, CA; Matin, RN; Rizvi, H | 1 |
| Badiglian-Filho, L; Baiocchi, G; Begnami, MD; Costa, FD; Faloppa, CC; Fukazawa, EM; Kumagai, LY; Oliveira, RA; Soares, FA; Surima, WS | 1 |
| Chu, J; Hartman, R; Meehan, S; Patel, R; Stein, JA | 1 |
| Feito, M; Gómez-Fernandez, C; Herranz, P; Sendagorta, E | 1 |
| Mengjun, B; Tasleem, MM; Zheng-Qiang, W | 1 |
| Flowers, FP; Hassenein, AM; Roth, WI; Zampogna, JC | 1 |
| Helm, T; Oseroff, AR; Qian, Z; Shieh, S; Zeitoun, NC | 1 |
| Blanchard, A; Busbey, S; Judge, DE; Lorincz, AA; Medenica, MM; Wang, LC | 1 |
| Berman, B; Elgart, G; Poochareon, V; Spencer, J; Villa, A | 1 |
| Huntley, A; Navi, D | 1 |
| Cohen, PR; Hetherington, GW; Nelson, BR; Schulze, KE; Tschen, JA | 1 |
| Badgwell, C; Rosen, T | 1 |
| Edelstein, L; Rhew, DC; Ye, JN; Yip, F | 1 |
| Ammoury, A; Bazex, J; El Sayed, F; Lamant, L; Messer, L; Mirer, E | 1 |
| Awada, A; Ghanem, G; Hendlisz, A; Larsimont, D; Marques da Costa, C; Mendes da Costa, P; Simoens, C; Vereecken, P | 1 |
| Misery, L | 1 |
| Hu, SL; Yeh, MH | 1 |
| Davis, JR; Hatch, KD | 1 |
| Flowers, F | 1 |
20 review(s) available for imiquimod and Extra-Mammary Paget Disease
| Article | Year |
|---|---|
Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease.
Topics: Aged; Humans; Imiquimod; Paget Disease, Extramammary; Prospective Studies; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2022 |
Treatment Outcomes of Adjunct and Stand-alone Photodynamic Therapy in Patients With Extramammary Paget Disease: A Literature Review.
Topics: Aminolevulinic Acid; Humans; Imiquimod; Paget Disease, Extramammary; Photochemotherapy; Photosensitizing Agents; Treatment Outcome | 2023 |
Network meta-analysis of treatments for perineal extramammary paget's disease: Focusing on performance of recurrence prevention.
Topics: Bayes Theorem; Female; Humans; Imiquimod; Male; Mohs Surgery; Neoplasm Recurrence, Local; Network Meta-Analysis; Paget Disease, Extramammary; Retrospective Studies | 2023 |
Paget's disease of the vulva: A challenge for the gynaecologist.
Topics: Administration, Topical; Antineoplastic Agents; Diagnosis, Differential; Female; Humans; Imiquimod; Lasers, Gas; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Photochemotherapy; Prognosis; Radiotherapy Dosage; Vulvar Neoplasms | 2021 |
Is There a Place for Immune Checkpoint Inhibitors in Vulvar Neoplasms? A State of the Art Review.
Topics: Adjuvants, Immunologic; Alphapapillomavirus; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Immune Checkpoint Inhibitors; Immunotherapy; Melanoma; Neuroendocrine Tumors; Paget Disease, Extramammary; Prognosis; Vulvar Neoplasms | 2020 |
Anogenital syringocystadenocarcinoma papilliferum in situ or anaplastic extramammary Paget disease? A unifying concept and review of the literature.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Carcinoma in Situ; Diagnosis, Differential; Epidermis; Female; Genital Neoplasms, Male; Humans; Imiquimod; Immunohistochemistry; Male; Middle Aged; Paget Disease, Extramammary; Sweat Gland Neoplasms; Treatment Outcome | 2021 |
Interventions for the treatment of Paget's disease of the vulva.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Imiquimod; Laser Therapy; Middle Aged; Paget Disease, Extramammary; Photochemotherapy; Randomized Controlled Trials as Topic; Vulvar Neoplasms | 2019 |
Imiquimod therapy for extramammary Paget's disease of the vulva: a viable non-surgical alternative.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Anti-Inflammatory Agents; Antineoplastic Agents; Clobetasol; Female; Humans; Imiquimod; Middle Aged; Paget Disease, Extramammary; Vulvar Neoplasms | 2013 |
The clinical evidence and the role of imiquimod in the extramammary Paget disease.
Topics: Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Paget Disease, Extramammary; Skin Neoplasms | 2014 |
Effects of imiquimod on vulvar Paget's disease: a systematic review of literature.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Paget Disease, Extramammary; Treatment Outcome; Vulvar Neoplasms | 2015 |
Paget's Disease of the Vulva Treated with Imiquimod: Case Report and Systematic Review of the Literature.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Paget Disease, Extramammary; Skin Cream; Vulvar Neoplasms | 2017 |
[Paget disease of the vulva: resolution after local treatment with imiquimod--report of a case and review of the literature].
Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Chemotherapy, Adjuvant; Colposcopy; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Imiquimod; Laser Therapy; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Vulva; Vulvar Neoplasms | 2009 |
Treatment of recurrent vulvar Paget disease with imiquimod cream: a case report and review of the literature.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Betamethasone; Emollients; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Treatment Outcome; Vulvar Neoplasms | 2011 |
Do lasers or topicals really work for nonmelanoma skin cancers?
Topics: Administration, Cutaneous; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chemexfoliation; Dermatologic Agents; Fluorouracil; Humans; Imiquimod; Laser Therapy; Nicotinic Acids; Paget Disease, Extramammary; Photochemotherapy; Skin Neoplasms | 2011 |
Extramammary Paget disease.
Topics: Aminoquinolines; Antineoplastic Agents; Asian People; Biopsy; Carcinoma, Squamous Cell; Combined Modality Therapy; Diagnostic Errors; Eczema; Humans; Imiquimod; Male; Middle Aged; Mohs Surgery; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Penile Neoplasms; Scrotum; Skin Neoplasms | 2011 |
Extramammary Paget's disease of the perianal region: a review of the literature emphasizing management.
Topics: Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Humans; Imiquimod; Paget Disease, Extramammary; Photochemotherapy; Skin Neoplasms | 2013 |
Treatment of primary limited cutaneous extramammary Paget's disease with topical imiquimod monotherapy: two case reports.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Diagnosis, Differential; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Paget Disease, Extramammary; Perineum; Scrotum; Skin Neoplasms | 2002 |
Imiquimod 5 percent cream and the treatment of cutaneous malignancy.
Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Line, Tumor; Clinical Trials as Topic; Condylomata Acuminata; Drug Screening Assays, Antitumor; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunity, Cellular; Immunologic Factors; Keratoacanthoma; Keratosis; Male; Melanoma; Multicenter Studies as Topic; Mycosis Fungoides; Ointments; Paget Disease, Extramammary; Precancerous Conditions; Randomized Controlled Trials as Topic; Skin Neoplasms | 2004 |
Treatment of extramammary Paget disease with topical imiquimod cream: case report and literature review.
Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Groin; Humans; Imiquimod; Male; Paget Disease, Extramammary; Skin Neoplasms | 2006 |
Extramammary Paget's disease resistant to surgery and imiquimod monotherapy but responsive to imiquimod combination topical chemotherapy with 5-fluorouracil and retinoic acid: a case report.
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Diagnosis, Differential; Fluorouracil; Genital Neoplasms, Male; Humans; Imiquimod; Male; Paget Disease, Extramammary; Tretinoin | 2006 |
2 trial(s) available for imiquimod and Extra-Mammary Paget Disease
| Article | Year |
|---|---|
Imiquimod 5% cream as a therapeutic option for extramammary Paget's disease.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Paget Disease, Extramammary; Prospective Studies; Remission Induction; Skin; Skin Cream; Skin Neoplasms; Treatment Outcome | 2018 |
A pilot study of topical imiquimod therapy for the treatment of recurrent extramammary Paget's disease.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Pilot Projects | 2016 |
48 other study(ies) available for imiquimod and Extra-Mammary Paget Disease
| Article | Year |
|---|---|
The Paget Trial: topical 5% imiquimod cream for noninvasive vulvar Paget disease.
Topics: Aminoquinolines; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Imiquimod; Paget Disease, Extramammary; Quality of Life; Vulvar Neoplasms | 2022 |
Vulvar Paget's disease: outcomes of 51 patients treated with imiquimod cream.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Imiquimod; Paget Disease, Extramammary; Retrospective Studies; Vulvar Neoplasms | 2022 |
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus statem
Topics: Carcinoma in Situ; Cidofovir; Colposcopy; Female; Genital Neoplasms, Female; Humans; Imiquimod; Melanoma; Melanoma, Cutaneous Malignant; Paget Disease, Extramammary; Pregnancy; Skin Neoplasms; Vulvar Neoplasms | 2022 |
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Statem
Topics: Carcinoma in Situ; Colposcopy; Female; Humans; Imiquimod; Melanoma; Melanoma, Cutaneous Malignant; Paget Disease, Extramammary; Pregnancy; Skin Neoplasms; Squamous Intraepithelial Lesions; Vulvar Neoplasms | 2022 |
Vulvar's Paget's disease treated with a combination of clock mapping and imiquimod.
Topics: Adenocarcinoma; Antineoplastic Agents; Humans; Imiquimod; Paget Disease, Extramammary | 2023 |
Patient's Experience With Imiquimod for Extramammary Paget Disease.
Topics: Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Paget Disease, Extramammary; Skin Neoplasms | 2023 |
Perianal Paget's Disease.
Topics: Administration, Cutaneous; Aged; Anal Canal; Antineoplastic Agents; Female; Humans; Imiquimod; Mohs Surgery; Paget Disease, Extramammary; Photochemotherapy; Radiotherapy; Skin Neoplasms | 2021 |
Initial topical monotherapy may increase the risk of recurrence in patients with extramammary Paget's disease.
Topics: Fluorouracil; Humans; Imiquimod; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Retrospective Studies | 2021 |
Combined methyl aminolevulinate-based photodynamic therapy and imiquimod in a patient with perianal extramammary Paget's disease.
Topics: Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Paget Disease, Extramammary; Photochemotherapy; Photosensitizing Agents | 2021 |
Paget's Disease of the Vulva: A Review of 20 Years' Experience.
Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Logistic Models; Middle Aged; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Vulvar Neoplasms | 2017 |
Extramammary Paget's disease of the scrotum with complete response to imiquimod and photodynamic therapy.
Topics: Administration, Topical; Aged; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Biopsy; Genital Neoplasms, Male; Humans; Imiquimod; Male; Paget Disease, Extramammary; Photochemotherapy; Photosensitizing Agents; Scrotum | 2018 |
Complete response of extramammary Paget's disease with imiquimod and PDT: Report of two cases.
Topics: Female; Humans; Imiquimod; Male; Middle Aged; Paget Disease, Extramammary; Photochemotherapy; Skin Neoplasms | 2018 |
Perianal extramammary Paget disease treated with topical imiquimod and oral cimetidine.
Topics: Administration, Oral; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Cimetidine; Female; Humans; Imiquimod; Immunologic Factors; Middle Aged; Mohs Surgery; Paget Disease, Extramammary | 2018 |
Rare perianal extramammary Paget disease successfully treated using topical Imiquimod therapy.
Topics: Administration, Topical; Aged; Antineoplastic Agents; Anus Neoplasms; Biomarkers, Tumor; Biopsy; Humans; Imiquimod; Immunohistochemistry; Male; Paget Disease, Extramammary; Treatment Outcome | 2018 |
Vulvar Paget disease: A national retrospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Disease-Free Survival; Female; Humans; Imiquimod; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Netherlands; Paget Disease, Extramammary; Retrospective Studies; Survival Rate; Vulvar Neoplasms; Vulvectomy | 2019 |
Topical Combination of Fluorouracil and Calcipotriene as a Palliative Therapy for Refractory Extramammary Paget Disease.
Topics: Administration, Topical; Aged; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Female; Fluorouracil; Humans; Imiquimod; Middle Aged; Paget Disease, Extramammary; Palliative Care; Retrospective Studies; Skin Neoplasms; Treatment Outcome | 2019 |
Extensive extramammary Paget's disease of the vulva involving the bladder postradical split skin graft reconstruction.
Topics: Aged, 80 and over; Antineoplastic Agents; Cystoscopy; Female; Gynecologic Surgical Procedures; Humans; Imiquimod; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Skin Transplantation; Urethral Neoplasms; Urinary Bladder Neoplasms; Vulvar Neoplasms | 2019 |
A Case of Chronic and Relapsing Paget Disease of the Vulva.
Topics: Aged; Antineoplastic Agents; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Plastic Surgery Procedures; Treatment Outcome; Vulvar Neoplasms; Vulvectomy | 2019 |
Treatment of extramammary Paget disease of the vulva with imiquimod: a retrospective, multicenter study by the German Colposcopy Network.
Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Analysis of Variance; Antineoplastic Agents; Cohort Studies; Colposcopy; Female; Follow-Up Studies; Germany; Humans; Imiquimod; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Paget Disease, Extramammary; Retrospective Studies; Risk Assessment; Survival Rate; Treatment Outcome; Vulvar Neoplasms | 2014 |
Complete remission of two patients with recurrent and wide spread extramammary Paget disease obtained from 5-aminolevulinic acid-based photodynamic therapy and imiquimod combination treatment.
Topics: Aged; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Drug Therapy, Combination; Genital Neoplasms, Male; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Photosensitizing Agents; Remission Induction; Skin Neoplasms; Treatment Outcome | 2014 |
Treatment of primary vulvar paget disease with 5% imiquimod cream.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Middle Aged; Paget Disease, Extramammary; Skin Cream; Treatment Outcome; Vulvar Neoplasms | 2014 |
Topical imiquimod in the treatment of extramammary Paget's disease: A 10 year retrospective analysis in an Asian tertiary centre.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Female; Humans; Imiquimod; Male; Paget Disease, Extramammary; Penile Neoplasms; Retrospective Studies; Singapore; Skin Cream; Sweat Gland Neoplasms; Tertiary Care Centers; Time Factors; Treatment Outcome; Vulvar Neoplasms | 2016 |
Imiquimod in vulvar Paget's disease: a case report.
Topics: Aged, 80 and over; Aminoquinolines; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Remission Induction; Treatment Outcome; Vulvar Neoplasms | 2008 |
Multidisciplinary treatment of vulval extramammary Paget's disease to maintain sexual function: an imiquimod success story.
Topics: Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Female; Humans; Imiquimod; Middle Aged; Paget Disease, Extramammary; Sexual Behavior; Vulvar Neoplasms | 2009 |
Mammary and extramammary Paget's disease: a study of 14 cases and the associated therapeutic difficulties.
Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Male; Middle Aged; Paget Disease, Extramammary; Paget's Disease, Mammary; Prostatic Neoplasms; Vulvar Neoplasms | 2009 |
Successful treatment of three cases of primary extramammary Paget's disease of the vulva with Imiquimod--proposal of a therapeutic schedule.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Drug Administration Schedule; Female; Humans; Imiquimod; Middle Aged; Paget Disease, Extramammary; Remission Induction; Skin Neoplasms; Vulvar Neoplasms | 2010 |
Extramammary Paget's disease of the penis with features of Bowen's disease.
Topics: Adjuvants, Immunologic; Aged; Aminoquinolines; Bowen's Disease; Humans; Imiquimod; Male; Paget Disease, Extramammary; Penile Diseases | 2009 |
Perineal extramammary Paget disease responsive to topical imiquimod.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Paget Disease, Extramammary; Perineum; Skin Neoplasms; Treatment Outcome | 2010 |
Vulvar puritus for one year.
Topics: Aminoquinolines; Antineoplastic Agents; Diagnosis, Differential; Female; Humans; Imiquimod; Middle Aged; Paget Disease, Extramammary; Pruritus Vulvae; Vaginal Creams, Foams, and Jellies; Vulvar Neoplasms | 2010 |
[Extramammary Paget disease treated with 5% imiquimod cream].
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Paget Disease, Extramammary; Pharmaceutical Preparations; Vulvar Neoplasms | 2011 |
Successful treatment of recurrent extramammary Paget's disease of the penis and scrotum with imiquimod 5% cream.
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Gels; Humans; Imiquimod; Male; Neoplasm Recurrence, Local; Osmolar Concentration; Paget Disease, Extramammary; Penile Neoplasms; Scrotum; Treatment Outcome | 2011 |
Failure of extensive extramammary Paget disease of the inguinal area to clear with imiquimod cream, 5%: possible progression to invasive disease during therapy.
Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Emollients; Groin; Humans; Imiquimod; Male; Paget Disease, Extramammary; Skin Neoplasms; Treatment Failure | 2011 |
[Extramammary Paget disease: successful therapy with imiquimod 5% cream].
Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Anus Neoplasms; Dermatologic Agents; Female; Humans; Imiquimod; Paget Disease, Extramammary | 2012 |
Clinical treatment of vulvar Paget's disease: a case report.
Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Female; Humans; Imiquimod; Paget Disease, Extramammary; Time Factors; Treatment Outcome; Vulvar Neoplasms | 2011 |
Extramammary Paget disease: failure to respond to topical imiquimod 5%.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Genital Neoplasms, Male; Humans; Imiquimod; Male; Paget Disease, Extramammary; Scrotum; Skin Neoplasms; Treatment Failure | 2011 |
Cutaneous mucinous carcinoma arising in extramammary Paget disease of the perineum.
Topics: Adenocarcinoma, Mucinous; Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Neoplasms, Multiple Primary; Paget Disease, Extramammary; Perineum; Skin Neoplasms; Vulvar Neoplasms | 2011 |
Conservative management of extramammary paget disease with imiquimod.
Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Skin Neoplasms; Treatment Outcome; Vulva; Vulvar Neoplasms | 2012 |
Sustained remission of extramammary Paget disease following treatment with imiquimod 5% cream.
Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Dosage Forms; Female; Humans; Imiquimod; Middle Aged; Paget Disease, Extramammary; Remission Induction; Vulvar Neoplasms | 2012 |
Successful treatment of extramammary Paget's disease with imiquimod.
Topics: Aged; Aminoquinolines; Humans; Imiquimod; Male; Paget Disease, Extramammary; Penile Neoplasms | 2003 |
Successful treatment of recurrent extramammary Paget's disease of the vulva with topical imiquimod 5% cream.
Topics: Adjuvants, Immunologic; Aged; Aminoquinolines; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Vulvar Neoplasms | 2003 |
Successful treatment of extramammary Paget's disease of the scrotum with imiquimod 5% cream.
Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Biopsy; Genital Neoplasms, Male; Humans; Imiquimod; Male; Paget Disease, Extramammary; Scrotum; Skin Neoplasms; Treatment Outcome | 2003 |
Treatment of limited extent extramammary Paget's disease with 5 percent imiquimod cream.
Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Drug Administration Schedule; Female; Humans; Imiquimod; Paget Disease, Extramammary; Skin Neoplasms; Thigh; Treatment Outcome | 2006 |
Treatment of mammary and extramammary Paget's skin disease with topical imiquimod.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Breast Neoplasms; Diagnosis, Differential; Female; Groin; Humans; Imiquimod; Paget Disease, Extramammary; Paget's Disease, Mammary; Skin Neoplasms | 2006 |
A therapeutic approach to perianal extramammary Paget's disease: topical imiquimod can be useful to prevent or defer surgery.
Topics: Administration, Topical; Aged; Aminoquinolines; Anal Canal; Antineoplastic Agents; Humans; Imiquimod; Male; Paget Disease, Extramammary; Skin Neoplasms | 2007 |
Treatment of genital Paget's skin disease with topical imiquimod: severe adverse events.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Diagnosis, Differential; Drug Hypersensitivity; Female; Genital Neoplasms, Female; Humans; Imiquimod; Paget Disease, Extramammary | 2007 |
Treatment of double ectopic extramammary Paget's disease of bilateral chest with imiquimod 5% cream.
Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Male; Paget Disease, Extramammary; Skin Neoplasms; Thorax | 2007 |
Complete resolution of Paget disease of the vulva with imiquimod cream.
Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Biopsy; Female; Follow-Up Studies; Humans; Imiquimod; Male; Ointments; Paget Disease, Extramammary; Vaginal Creams, Foams, and Jellies; Vulvar Neoplasms | 2008 |
Imiquimod in the treatment of actinic keratoses and other intraepithelial neoplasms.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Bowen's Disease; Cicatrix; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythema; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Keratosis; Paget Disease, Extramammary; Photochemotherapy; Pruritus; Randomized Controlled Trials as Topic; Skin Neoplasms | 2002 |